Who are the key players in North America Urology Devices Market industry?

The top five players in the North America urology devices market are Boston Scientific Corporation, Medtronic plc, Olympus Corporation, Cook Medical, and Becton, Dickinson and Company (BD). These companies lead innovation with strong product portfolios, comprehensive distribution networks, and ongoing investments in research targeting minimally invasive urological procedures.

What is the North America Urology Devices Market growth?

The North America urology devices market is witnessing robust growth, driven by the increasing prevalence of urological disorders and product innovation. For instance, Boston Scientific reported double-digit growth in their urology segment in 2023, attributed to new product launches and rising demand for minimally invasive solutions.

Which segment accounted for the largest North America Urology Devices Market share?

The urinary incontinence and pelvic organ prolapse segment holds the largest market share, supported by a growing aging population and increasing incidence of these conditions. Advanced sling systems and catheters by key companies further boost this segment's adoption, solidifying its leadership within overall urology applications.

What are the factors driving the North America Urology Devices Market?

Rising adoption of minimally invasive surgeries, the launch of technologically advanced devices, and increasing patient awareness of urological health are driving the market. For example, Medtronic’s expansion of its urological health portfolio with advanced laser devices has improved treatment outcomes and fueled segment growth.

Which type accounted for the largest North America Urology Devices Market share?

Urological endoscopes accounted for the largest market share, owing to their critical role in diagnosis and treatment of various urological conditions. High adoption rates, continual technological improvements from companies like Olympus Corporation, and greater efficiency in minimally invasive procedures contribute to the dominance of this device type.

Home Healthcare

North America Urology Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Urology Devices Market
Brand: Bussiness Insights

North America Urology Devices Market: by Type (Dialysis Devices, Urology Endoscopes, Laser Systems, Urodynamic Systems, Robotic Systems, Stents, Others), Application (Kidney Diseases, Urological Cancer & BPH, Pelvic Organ Prolapse, Other Applications), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Tenders, Distributors, Others), Technology (Minimally Invasive, Non-Invasive, Robotic-Assisted, Conventional, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20461

North America Urology Devices Market Analysis (2025-2035)

The North America Urology Devices Market is poised for considerable growth between 2025 and 2035, driven by technological advancements, rising prevalence of urological disorders, and increasing adoption of minimally invasive surgical procedures. The sector is marked by robust investments from major medical device companies and the emergence of innovative diagnostic and treatment solutions targeting kidney diseases, urological cancers, and incontinence. Additionally, the expanding presence of online pharmacies and evolving healthcare infrastructure support sustained market momentum.

Latest Market Dynamics

Key Drivers

Rising prevalence of kidney diseases and urological cancers, pushing demand for advanced diagnostic and treatment devices. For instance, Boston Scientific reported a surge in its urology division revenue in 2024, citing increased adoption of its innovative minimally invasive solutions.
Accelerating shift towards minimally invasive and robotic-assisted procedures for improved patient outcomes—with

expanding its da Vinci robotic platforms across major U.S. hospital networks in early 2024.

Enhanced integration of AI and data analytics in urology diagnostics and device management, evidenced by Siemens Healthineers' launch of AI-powered platforms for urological imaging in late 2024.
Growth of home-based and wearable urology monitoring devices, as seen with Baxter International introducing remote patient management tools for dialysis devices in June 2024.

Key Opportunities

Expansion of tele-urology and remote monitoring platforms for chronic disease management, supported by Medtronic’s investment in cloud-based patient care systems.
Untapped potential in treating pelvic organ prolapse and urinary incontinence with next-generation implants, highlighted by Coloplast's FDA clearance for their novel mesh-free solutions in July 2024.

Stringent regulatory approval processes limiting rapid product entry, as observed with delays in new device launches reported by Stryker Corporation in Q3 2024.
Interoperability issues among urology device ecosystems, compounded by fragmented data standards across hospital networks and emphasized in recent launches by Siemens Healthineers.

High upfront costs associated with robotic and advanced minimally invasive systems, impacting adoption rates in small to mid-sized healthcare organizations, cited in recent reports by Fresenius Medical Care.
Ongoing shortages in specialized healthcare workforce and training required for next-generation urology devices, as underscored by the 2024 strategic reviews from Cook Medical.

Market Share by Type, 2025

Dialysis Devices hold the leading share in the North America Urology Devices Market, owing to the rising burden of chronic kidney diseases and the growing number of dialysis patients. Urology Endoscopes and Laser Systems follow, attributed to widespread deployment in minimally invasive procedures for treating kidney stones, tumors, and other urological conditions. The robust adoption of robotic systems further propels the technological shift across healthcare facilities.

Market Share by Application, 2025

Kidney Diseases represent the largest application segment, reflecting the high incidence rates and treatment volumes in North America. Urological Cancer & BPH are notable for their significant demand for advanced diagnostic and therapeutic technologies. Pelvic Organ Prolapse and incontinence solutions are gaining momentum as awareness grows and new product innovations reach market. The landscape is evolving with targeted investments in chronic disease management.

Market Revenue (USD Million), 2020-2035

The North America Urology Devices Market was valued at 12,400 Million USD in 2025. Fueled by continued innovation and healthcare investments, the market is projected to register a steady growth trajectory, reaching an estimated 22,800 Million USD by 2035. The upward trend is supported by increasing device adoption across both large hospitals and outpatient care settings.

YOY (%) Growth, 2020-2035

Year-over-year growth rates in the North America Urology Devices Market remain positive over the forecast period. An acceleration in adoption is seen around 2027-2029 due to regulatory clearances and novel product launches. Growth is expected to stabilize at a strong CAGR through 2035, driven by healthcare digitization and patient-centric device innovation.

Market Share by Region, 2025

The U.S. dominates the regional market landscape with over 73% share, benefiting from advanced healthcare infrastructure, high healthcare spending, and prolific adoption of cutting-edge technologies. Canada represents a strong secondary market owing to government initiatives and aging demographics, while Mexico’s share is rising as healthcare modernization accelerates.

Market Players Share, 2025

Boston Scientific Corporation leads in market share at 19%, followed by Baxter International and Olympus Corporation with 14% and 10% respectively. Siemens Healthineers AG and Medtronic are also key contributors. The competitive landscape is sustained by innovation pipelines and strong distribution networks across North America.

Market Buyers Share, 2025

Hospital Pharmacies account for the largest proportion (36%) of total device purchases, reflecting the reliance on institutional procurement channels. Direct Tenders and Retail Pharmacies trail closely behind, underlying the complexity and diversity of the supply chain in North America. Online channels and distributors are gaining share as patient and clinician preferences shift.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	12400
Regions	US, Canada, Mexico
Segments	By Type, By Application, By Distribution Channel, By Technology, By Organization Size
Players	Boston Scientific Corporation, Baxter International Inc., Olympus Corporation, Siemens Healthineers AG, Medtronic, Stryker Corporation, Fresenius Medical Care AG & Co. KGaA, Cook Medical, Coloplast, C. R. Bard (Becton, Dickinson and Company), Dornier MedTech, Intuitive Surgical, Richard Wolf GmbH, KARL STORZ SE & Co. KG, Teleflex Incorporated

Key Recent Developments

June 2024: Olympus Corporation announced the launch of a next-gen flexible ureteroscope in the U.S. market to enhance minimally invasive kidney stone management.
July 2024: Coloplast received FDA clearance for its innovative mesh-free pelvic organ prolapse solution, targeting improved incontinence outcomes.
August 2024: Siemens Healthineers rolled out AI-powered urology imaging systems across major U.S. hospital chains, accelerating precision diagnosis.
September 2024: Intuitive Surgical expanded its da Vinci SP platform deployment, further integrating robotic-assisted solutions in key North American academic centers.
October 2024: Baxter International introduced a remote patient monitoring suite for home dialysis, addressing rising demand for decentralized urology care.

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates